Editorial: Glucocorticoid replacement - How much is enough?

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 3, 2006, Pages 793-794

  Lukert, Barbara P ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PREDNISOLONE; PREDNISONE; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ADDISON DISEASE; BONE DENSITY; CONGENITAL ADRENAL HYPERPLASIA; CORRELATION ANALYSIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; CORTICOTROPIN RELEASE; CUSHING SYNDROME; DOSE RESPONSE; DRUG EFFECT; DRUG HALF LIFE; EDITORIAL; FRACTURE; HUMAN; HYPOPITUITARISM; OSSIFICATION; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENAL INSUFFICIENCY; CUSHING SYNDROME; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPITUITARISM;

EID: 33644818251     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2737     Document Type: Editorial

References (12)

1. Peacey SR, Chun-Yuan G, Robinson AM, Price A, Giles MA, Eastell R, Weetman AR 2000 Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) 46:255-261
2. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC 1998 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274-282
3. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S 1999 Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389
4. Canalis E, Giustina A 2001 Glucocorticoid-induced osteoporosis: summary of a workshop. J Clin Endocrinol Metab 86:5681-5685
5. Delaney AM, Durant D, Canalis E 2001 Glucocorticoid suppression of IGF I transcription in osteoblasts. Mol Endocrinol 1781-1789
6. Centrella M, McCarthy TL 2000 Glucocorticoid regulation of transforming growth factor β1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol 11:4490-4496
7. Ohnaka K, Tanabe M, Kawate H, Nawata H, Takayanagi R 2005 Glucocorticoids suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem Biophys Res Commun 329:177-181
8. King JA, Wisniewski AB, Bankowski BJ, Carson KA, Zacur HA, Migeon CJ 2006 Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 91:865-869
9. Van Staa TP, Leufkens HGM, Abenhaim L 2000 Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-999
10. Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, Stewart PM 2002 Osteoblastic 11β-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res 17:979-986
11. Cohen N, Gilbert R, Wirth A, Casley D, Jerums G 1996 Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease. J Clin Endocrinol Metab 81:1411-1415
12. Esteban NV, Loughlin T, Yergey AZ, Zawadzki JK, Booth JD, Winterer JC, Loriaux DL 1991 Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 72:1698-1700